News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bohen Sean
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2022 |
4/A
| Bohen Sean (PRESIDENT AND CEO) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $0 |
|
| 09/22/2022 |
4
| Bohen Sean (PRESIDENT AND CEO) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 10/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2020 |
4
| Bohen Sean (President and CEO) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 82,931 options to buy
@ $4.824, valued at
$400.1k
Granted 1,027,965 options to buy
@ $4.824, valued at
$5M
Exercised 51,649 options to buy
@ $4.824, valued at
$249.2k
Granted 538,020 options to buy
@ $19, valued at
$10.2M
|
|
| 11/18/2020 |
3
| Bohen Sean (President and CEO) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
|
|